Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders — Stella

Home/Childhood-onset Systemic Lupus Erythematous/Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

View on ClinicalTrials.gov

Recruiting

Back to Childhood-onset Systemic Lupus Erythematous trials

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

H01- Children's National Hospital, Washington D.C., District of Columbia

H03- Washington University School of Medicine, St Louis, Missouri

Key details

Phase

Early testing / Safety & dosing

Sponsor

Cartesian Therapeutics

Enrollment target

~50 participants

Started

January 2026

Primary completion

December 2027

Age range

12 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.